Can thyroidectomy be considered safe in obese patients? A retrospective cohort study.
BMI
Body mass index
Complications
Endocrine surgery
Obesity
Thyroidectomy
Journal
BMC surgery
ISSN: 1471-2482
Titre abrégé: BMC Surg
Pays: England
ID NLM: 100968567
Informations de publication
Date de publication:
07 Nov 2020
07 Nov 2020
Historique:
received:
28
04
2020
accepted:
29
10
2020
entrez:
8
11
2020
pubmed:
9
11
2020
medline:
12
1
2021
Statut:
epublish
Résumé
Obesity is a growing public health concern in most western countries. More and more patients with high body mass index (BMI) are undergoing surgical procedures of all kinds and, in this context, obese patients are undergoing thyroid surgery more than ever before. The aim of the present study was to evaluate whether thyroidectomy can be considered safe in obese patients. Patients undergoing thyroidectomy in our Unit between January 2014 and December 2018 were retrospectively analysed. Patients were divided into two groups: those with BMI < 30 kg/m A total of 813 patients were included in this study: 31 (3.81%) were underweight, 361 (44.40%) normal-weight, 286 (35.18%) overweight, 94 (11.57%) obese and 41 (5.04%) morbidly obese. Six hundred and seventy-eight patients were included in Group A and 135 in Group B. At univariate analysis, the comparison between the two groups, in terms of operative time and thyroid weight resulted in statistically significant results (P = 0.001, P = 0.008; respectively). These features were significantly higher in Group B than in Group A. About postoperative stay and complications, no statistically significant difference was found between the two groups. At multivariate analyses, only the development of cervical haematoma was statistically significantly correlated to the BMI value. Patients with high BMI had a lower risk of cervical haematoma (P = 0.045, OR 0.797, 95% CI 0.638-0.995). This study showed that obesity, in the field of thyroid surgery, is not associated with any increase of postoperative complications. Thus, it is possible to conclude that thyroidectomy can be performed safely in obese patients. Our result about operative times had no clinical significance.
Sections du résumé
BACKGROUND
BACKGROUND
Obesity is a growing public health concern in most western countries. More and more patients with high body mass index (BMI) are undergoing surgical procedures of all kinds and, in this context, obese patients are undergoing thyroid surgery more than ever before. The aim of the present study was to evaluate whether thyroidectomy can be considered safe in obese patients.
METHODS
METHODS
Patients undergoing thyroidectomy in our Unit between January 2014 and December 2018 were retrospectively analysed. Patients were divided into two groups: those with BMI < 30 kg/m
RESULTS
RESULTS
A total of 813 patients were included in this study: 31 (3.81%) were underweight, 361 (44.40%) normal-weight, 286 (35.18%) overweight, 94 (11.57%) obese and 41 (5.04%) morbidly obese. Six hundred and seventy-eight patients were included in Group A and 135 in Group B. At univariate analysis, the comparison between the two groups, in terms of operative time and thyroid weight resulted in statistically significant results (P = 0.001, P = 0.008; respectively). These features were significantly higher in Group B than in Group A. About postoperative stay and complications, no statistically significant difference was found between the two groups. At multivariate analyses, only the development of cervical haematoma was statistically significantly correlated to the BMI value. Patients with high BMI had a lower risk of cervical haematoma (P = 0.045, OR 0.797, 95% CI 0.638-0.995).
CONCLUSIONS
CONCLUSIONS
This study showed that obesity, in the field of thyroid surgery, is not associated with any increase of postoperative complications. Thus, it is possible to conclude that thyroidectomy can be performed safely in obese patients. Our result about operative times had no clinical significance.
Identifiants
pubmed: 33160350
doi: 10.1186/s12893-020-00939-w
pii: 10.1186/s12893-020-00939-w
pmc: PMC7648980
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
275Références
Mol Cell Endocrinol. 2010 Mar 25;316(2):165-71
pubmed: 19540303
Head Neck. 2019 Sep;41(9):2952-2959
pubmed: 31002213
Am J Surg. 2019 Jan;217(1):142-145
pubmed: 30389117
Arch Surg. 2012 Sep;147(9):805-11
pubmed: 22914989
Tumour Biol. 2016 Nov;37(11):14363-14380
pubmed: 27623943
BMC Surg. 2019 Apr 24;18(Suppl 1):116
pubmed: 31074389
Lancet. 2016 Aug 20;388(10046):776-86
pubmed: 27423262
Surgery. 2014 Nov;156(5):1145-52
pubmed: 24878452
Gland Surg. 2017 Oct;6(5):510-515
pubmed: 29142842
Eur J Endocrinol. 2014 Jul;171(1):99-105
pubmed: 24913199
Am J Surg. 2017 Nov;214(5):899-903
pubmed: 28219624
J Am Coll Surg. 2014 Jun;218(6):1231-7
pubmed: 24745620
Updates Surg. 2019 Dec;71(4):705-710
pubmed: 30937820
Cancer Control. 2019 Jan-Dec;26(1):1073274819853831
pubmed: 31480878
Int J Surg. 2016 Apr;28 Suppl 1:S38-41
pubmed: 26708851
Thyroid. 2014 Jul;24(7):1146-50
pubmed: 24684421
Surg Neurol Int. 2017 Apr 26;8:66
pubmed: 28540132
Open Med (Wars). 2019 Jun 07;14:437-442
pubmed: 31231683
Surgery. 2011 Nov;150(5):950-8
pubmed: 21621238
Int J Surg. 2017 May;41 Suppl 1:S13-S20
pubmed: 28506407
Dis Colon Rectum. 2017 Apr;60(4):433-445
pubmed: 28267012
Minerva Chir. 2019 Jun;74(3):277-278
pubmed: 30665291